NeuroVive Pharmaceutical (Sweden)

Recent papers from NeuroVive Pharmaceutical (Sweden)

1. Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver micePLoS ONE · 2020
2. Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdosePLoS ONE · 2020
3. Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver FibrosisCells · 2019
4. Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic SteatohepatitisFrontiers in Pharmacology · 2019
5. Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury PatientsJournal of Neurotrauma · 2019
6. Neuroprotective Effects of Cyclosporine in a Porcine Pre-Clinical Trial of Focal Traumatic Brain InjuryJournal of Neurotrauma · 2018
7. Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiencyNature Communications · 2016
8. Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibitionActa Physiologica · 2014
9. Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® ELClinical Drug Investigation · 2012